Company Filing History:
Years Active: 1980
Title: Zen-ichi Henmi: Innovator in Anti-Ulcer Pharmaceutical Composition
Introduction
Zen-ichi Henmi is a notable inventor based in Mobara, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of anti-ulcer compositions. With a total of 2 patents, his work has garnered attention for its potential impact on gastrointestinal health.
Latest Patents
Henmi's latest patents focus on anti-ulcer pharmaceutical compositions containing inositol hexasulfate. These compositions, which include aluminum and sodium aluminum salts, exhibit excellent anti-ulcer, antacid, and antipeptic effects. Research has demonstrated that these compounds effectively inhibit various types of experimental gastric and duodenal ulcers in rats, including Shay's ulcer, acetic acid ulcer, stress ulcer, cysteamine duodenal ulcer, and aspirin ulcer. Furthermore, studies on the action of these compounds reveal their beneficial effects on gastric juice secretion, acidity, and pepsin activity.
Career Highlights
Zen-ichi Henmi is associated with Mitsui Toatsu Chemicals, Incorporated, where he has been instrumental in advancing pharmaceutical innovations. His research and development efforts have contributed to the understanding and treatment of gastric conditions.
Collaborations
Henmi has collaborated with notable colleagues, including Akira Kotaki and Takafumi Kitano. Their combined expertise has furthered the research and development of effective pharmaceutical solutions.
Conclusion
Zen-ichi Henmi's contributions to the field of anti-ulcer pharmaceuticals highlight his innovative spirit and dedication to improving health outcomes. His work continues to influence the development of effective treatments for gastric ailments.